Patient-derived organoid models of malignant phyllodes tumors for drug sensitivity testing and identification of targeted therapeutic strategies

Background Malignant phyllodes tumors (MPT) of the breast are rare fibroepithelial neoplasms. It exhibits rapid growth, large size, and a high local recurrence rate.